Dentsply Sirona price target lowered to $13 from $15 at Stifel

Stifel lowered the firm’s price target on Dentsply Sirona (XRAY) to $13 from $15 and keeps a Hold rating on the shares. The Q3 earnings call had more fireworks than expected, the firm says. Management lowered 2025 guidance, and the company will again undergo a new CFO search, as Matt Garth has departed after only 5 months on the job. While the lower 2025 exit rate negatively impacts Stifel’s 2026/2027 estimates, new CEO Dan Scavilla talked in detail about his return to growth action plan, which the firm believes may start to pay dividends in the second half of 2026.